Skip to main navigation
Skip to search
Skip to main content
Arizona State University Home
Home
Profiles
Departments and Centers
Scholarly Works
Activities
Equipment
Grants
Datasets
Prizes
Search by expertise, name or affiliation
Novel tunable DNA-nanostructure vaccines against drugs of abuse
Yung Chang
(Inventor),
Sidney Hecht
(Inventor),
Hao Yan
(Inventor)
Arizona State University
Research output
:
Patent
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Novel tunable DNA-nanostructure vaccines against drugs of abuse'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Nicotine
100%
Drugs of Abuse
100%
DNA Nanostructures
100%
Cocaine
50%
Amphetamine
50%
Antibody Production
50%
Conventional Strategy
50%
Anti-nicotine Antibody
50%
Arizona State University
25%
Biodesign
25%
Sequester
25%
Well-defined
25%
Vaccine Development
25%
Optimal Configuration
25%
Intermolecular Interactions
25%
Tumor Antigen
25%
Target Antigen
25%
Substance Abuse
25%
Screening Method
25%
Mouse Model
25%
Self-assembly
25%
Rationally Designed
25%
Health Risk
25%
Infectious Agents
25%
Addiction
25%
Targets of Interest
25%
National Health Interview Survey
25%
Antibody Response
25%
Curb
25%
Active Immunity
25%
Nicotine Vaccine
25%
Spatial Orientation
25%
Cigarette
25%
Health Effects
25%
Quickest Detection
25%
Systematic Identification
25%
Spatial Distance
25%
Smoke Cigarette
25%
In Vitro Screening
25%
Addictive Drugs
25%
Medicine and Dentistry
Nanomaterial
100%
Amphetamine Derivative
66%
Antibody Generation
66%
Vaccine Development
33%
Tumor Antigen
33%
Substance Abuse
33%
Screening
33%
Addictive Behavior
33%
Health Hazard
33%
Active Immunization
33%
Antibody Response
33%
Cigarette Smoke
33%
In Vitro Screening
33%
Nicotine Vaccine
33%
Pharmacology, Toxicology and Pharmaceutical Science
Nanomaterial
100%
Amphetamine Derivative
66%
Mouse Model
33%
Tumor Antigen
33%
Infectious Agent
33%
Vaccine Development
33%
Health Hazard
33%
Intermolecular Interaction
33%
Nicotine Vaccine
33%
Cigarette Smoke
33%
In Vitro Screening
33%